We are live on ! Find out more
AGRX

Agile Therapeutics

Delisted

AGRX was delisted on the 25th of March, 2024.

46 hedge funds and large institutions have $63.4M invested in Agile Therapeutics in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,900% more call options, than puts

Call options by funds: $40K | Put options by funds: $1K

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

2% more funds holding

Funds holding: 4546 (+1)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 13

3% less capital invested

Capital invested by funds: $65.5M → $63.4M (-$2.06M)

Holders
46
Holders Change
+1
Holders Change %
+2.22%
% of All Funds
1.05%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
6
Increased
13
Reduced
13
Closed
5
Calls
$40K
Puts
$1K
Net Calls
+$39K
Net Calls Change
-$233K
Name Holding Trade Value Shares
Change
Change in
Stake
Squarepoint
51
Squarepoint
New York
-$63K -12 Closed
AGM
52
Alpine Global Management
New York
-$59K -11 Closed
CG
53
Cutler Group
California
-$1K
MIM
54
Monashee Investment Management
Massachusetts
-$44K